Literature DB >> 25301774

Salviprzols A and B, C₂₁- and C₂₂-terpenoids from the roots of Salvia przewalskii Maxim.

Yongbo Xue1, Ye Wu2, Hucheng Zhu2, Xiao-Nian Li3, Jin-Fu Qian4, Yongji Lai5, Chunmei Chen2, Guangmin Yao2, Zengwei Luo2, Yan Li3, Yonghui Zhang6.   

Abstract

Two C₂₁- and C₂₂-terpenoids, salviprzols A (1) and B (2), together with 24 known compounds including 17 diterpenoids (3-19), a triterpenoid (20), and 6 phenolic derivatives (21-26), were isolated from the roots of Salvia przewalskii Maxim. Salviprzols A and B represented a new subtype of C₂₃-terpenoids featured by an additional 2-oxopropyl moiety at C-12 and a rare γ-hydroxyl-α-methyl-α,β-unsaturated-γ-lactone ring system. Their structures were elucidated by extensive spectroscopic analyses, and the structure of 2 was confirmed by a single-crystal X-ray diffraction crystallography. The cytotoxic activities of the new isolates were tested. A plausible biosynthetic pathway for 1 and 2 was also proposed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C(23)-terpenoids; Labiatae; Salvia przewalskii; Salviprzols; X-ray diffraction

Mesh:

Substances:

Year:  2014        PMID: 25301774     DOI: 10.1016/j.fitote.2014.09.022

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  3 in total

1.  Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from Salvia przewalskii Maxim.

Authors:  Xiangdong Su; Yichuang Wu; Meifang Wu; Jielang Lu; Shujie Jia; Xin He; Shuna Liu; Yuyang Zhou; Hui Xing; Yongbo Xue
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

Review 2.  Furo[3,2-c]coumarins carrying carbon substituents at C-2 and/or C-3. Isolation, biological activity, synthesis and reaction mechanisms.

Authors:  Iván Cortés; L Javier Cala; Andrea B J Bracca; Teodoro S Kaufman
Journal:  RSC Adv       Date:  2020-09-10       Impact factor: 4.036

3.  The effects of Salvia przewalskii total phenolic acid extract on immune complex glomerulonephritis.

Authors:  Yang Yang; Zhi-Peng Wang; Shou-Hong Gao; Hong-Qi Ren; Ren-Qian Zhong; Wan-Sheng Chen
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.